CAPTRUST Financial Advisors
CSTL icon

CAPTRUST Financial Advisors’s Castle Biosciences CSTL Stock Holding History

CAPTRUST Financial Advisors’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-215,322
Closed -$5.74M – 2379
2024
Q4 		$5.74M Buy
215,322
+207,250
+2,568% +$6.31M 0.02% 502
2024
Q3 		$230K Sell
8,072
-13,053
-62% -$332K ﹤0.01% 2050
2024
Q2 		$460K Buy
21,125
+75
+0.4% +$1.67K ﹤0.01% 1550
2024
Q1 		$466K Sell
21,050
-17,359
-45% -$378K ﹤0.01% 1520
2023
Q4 		$829K Sell
38,409
-324
-0.8% -$5.7K ﹤0.01% 1387
2023
Q3 		$654K Sell
38,733
-190,958
-83% -$3.34M ﹤0.01% 1468
2023
Q2 		$3.15M Buy
229,691
+60,959
+36% +$1.24M 0.01% 659
2023
Q1 		$3.83M Buy
+168,732
New +$4.12M 0.02% 536
2022
Q3 		– Sell
-497
Closed -$11K – 2491
2022
Q2 		$11K Buy
497
+31
+7% +$720 ﹤0.01% 3688
2022
Q1 		$21K Buy
466
+34
+8% +$1.41K ﹤0.01% 3347
2021
Q4 		$19K Sell
432
-67
-13% -$3.5K ﹤0.01% 3302
2021
Q3 		$33K Buy
499
+65
+15% +$4.57K ﹤0.01% 2842
2021
Q2 		$32K Buy
434
+389
+864% +$25.7K ﹤0.01% 2794
2021
Q1 		$3K Buy
+45
New +$3.38K ﹤0.01% 3899

Other funds holding CSTL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

CAPTRUST Financial Advisors's CSTL Position: Q1 2025 in Review

CAPTRUST Financial Advisors sold out of Castle Biosciences (CSTL) in Q1 2025, closing a stake of 215,322 shares — an estimated $5.74M sold.

CAPTRUST Financial Advisors first reported a position in CSTL in Q1 2021 and held it in 14 quarters. The position peaked at $5.74M in Q4 2024. 180 funds tracked by Wall St. Rank hold CSTL as of Q1 2025.

  • CAPTRUST Financial Advisors reported no remaining Castle Biosciences position as of Q1 2025 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 215,322 Castle Biosciences shares in Q1 2025, an estimated $5.74M.
  • CAPTRUST Financial Advisors first reported a position in Castle Biosciences in Q1 2021 and held it in 14 quarters.
  • CAPTRUST Financial Advisors's Castle Biosciences position peaked at $5.74M in Q4 2024.
  • 180 funds tracked by Wall St. Rank held Castle Biosciences as of Q1 2025.

Based on CAPTRUST Financial Advisors's 13F filing for Q1 2025, filed 15 May 2025.